TASER International, Inc. Reports 23 Percent Revenue Growth in Second Quarter 2006

$16.2 Million of Revenue and 13.7 Percent Operating Margin


SCOTTSDALE, Ariz., July 26, 2006 (PRIMEZONE) -- TASER International, Inc. (Nasdaq:TASR) a market leader in advanced electronic control devices reported today that revenues for the second quarter of 2006 were $16.2 million, a 23% increase over the same quarter of the prior year. Operating income for the quarter was $2.2 million, or a 224% increase compared with $686,000 in the prior year period. Net income and basic and diluted earnings per share for the second quarter were $1.5 million which rounds down to $0.02 per share. Business also continued to improve sequentially as revenues in the second quarter of 2006 increased by $2.3 million over the first quarter of 2006 and operating income improved from 7.5% to 13.7% of revenue as the Company continues to improve its operating leverage. The Company generated $4.1 million of cash from operations in the second quarter of 2006 which increased the total cash, cash equivalents and investments balance to $49.1 million.

Significant events in the second quarter of 2006 include:


 1. The Company commenced shipping of its first TASER Cam(tm)
    production units following a BETA test and evaluation of field
    results.

 2. Maricopa County Sheriff's Office in Arizona announced plans to arm
    1,900 of 2,200 officers with the TASER(r) X26 as well as the TASER
    Cam, which will represent both the first major TASER system
    deployment in a correctional facility and the first large
    deployment of the TASER Cam in the U.S.  The Company received
    orders for and shipped approximately $0.5 million worth of product
    to the Maricopa County Sheriff's office in the second quarter after
    the first order in the planned roll out was received.

 3. The Company received sizeable orders from San Diego Police
    Department, Charlotte-Mecklenburg Police in North Carolina and
    export re-orders from international customers demonstrating
    continuing momentum in demand for TASER devices.

 4. Ten more product liability suits were dismissed representing a
    total of twenty-two wrongful death or injury lawsuits that have
    been dismissed, or judgment entered in favor of the Company in the
    past 24 months.

 5. The Company received notification from the United States Securities
    and Exchange Commission (SEC) that its investigation has been
    terminated in its entirety with no recommendation for enforcement
    action.

"We are pleased with the continuing momentum of product acceptance in the market place evidenced by the continued growth in net sales and the fulfillment of some significant law enforcement agency and international orders during the quarter," commented Rick Smith, Chief Executive Officer of TASER International, Inc.

The Company will be hosting its second quarter 2006 earnings conference call on July 26, 2006 at 10:00 a.m. E.D.T. The conference call is available via web cast and can be accessed on the "Investor Relations" page at www.TASER.com. To access the teleconference, please dial: 800-706-7745 or 617-614-3472 for international callers. The pass code is 49381522 for both numbers.

About TASER International, Inc.

TASER International, Inc. provides advanced non-lethal devices for use in the law enforcement, military, private security and personal defense markets. TASER devices use proprietary technology to safely incapacitate dangerous, combative, or high-risk subjects who pose a risk to law enforcement officers, innocent citizens or themselves. TASER technology saves lives every day, and the use of TASER devices dramatically reduces injury rates for police officers, and suspects.

Note to Investors

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements, without limitation, regarding our expectations, beliefs, intentions or strategies regarding the future. We intend that such forward-looking statements be subject to the safe-harbor provided by the Private Securities Litigation Reform Act of 1995. The forward-looking information is based upon current information and expectations regarding TASER International, Inc. These estimates and statements speak only as of the date on which they are made, are not guarantees of future performance, and involve certain risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results could materially differ from what is expressed, implied, or forecasted in such forward-looking statements.

TASER International, Inc. assumes no obligation to update the information contained in this press release. These statements are qualified by important factors that could cause our actual results to differ materially from those reflected by the forward-looking statements. Such factors include but are not limited to: (1) market acceptance of our products; (2) our ability to establish and expand direct and indirect distribution channels; (3) our ability to attract and retain the endorsement of key opinion-leaders in the law enforcement community; (4) the level of product technology and price competition for our products; (5) the degree and rate of growth of the markets in which we compete and the accompanying demand for our products; (6) risks associated with rapid technological change and new product introductions; (7) competition; (8) litigation including lawsuits resulting from alleged product related injuries and death; (9) media publicity concerning allegations of deaths and injuries occurring after use of the TASER device and the negative effect this publicity could have on our sales; (10) TASER device tests and reports; (11) product quality; (12) implementation of manufacturing automation; (13) potential fluctuations in our quarterly operating results; (14) financial and budgetary constraints of prospects and customers; (15) order delays; (16) dependence upon sole and limited source suppliers; (17) negative reports concerning TASER device uses; (18) fluctuations in component pricing; (19) government regulations and inquiries; (20) dependence upon key employees and our ability to retain employees; (21) execution and implementation risks of new technology; (22) ramping manufacturing production to meet demand; (23) medical and safety studies and (24) other factors detailed in our filings with the Securities and Exchange Commission, including, without limitation, those factors detailed in the Company's Annual Report on Form 10-K and its Form 10-Qs.

The statements made herein are independent statements of TASER International, Inc. The inclusion of any third parties does not represent an endorsement of any TASER International products or services by any such third parties.

For further information contact Marcy Rigoni, Manager of Investor Relations at Marcy@TASER.com or call 800-978-2737 ext. 2011, or Dan Behrendt, Chief Financial Officer of TASER International, Inc., +1-480-905-2002. Visit the company's web-site at www.TASER.com for facts and video.


                       TASER International, Inc.
                         Statements of Income
                              (Unaudited)

                                     For the Three Months Ended
                                     --------------------------
                                    June 30, 2006   June 30, 2005
                                    -------------   -------------
 Net Sales                           $ 16,225,197    $ 13,206,659
                                     ------------    ------------

 Cost of Products Sold:
 Direct manufacturing expense           4,229,384       3,525,670
 Indirect manufacturing expense
  (including stock-based
  compensation expense of $30,711
  and $0, respectively)                 1,605,190       1,489,466
                                     ------------    ------------

 Total Cost of Products Sold            5,834,574       5,015,136
                                     ------------    ------------

 Gross Margin                          10,390,623       8,191,523

 Sales, general and administrative
  expenses (including stock-based
  compensation expense of $233,236
  and $0, respectively)                 7,603,035       7,110,265
 Research and development expenses
  (including stock-based
  compensation expense of $47,701
  and $0, respectively)                   562,991         395,541
                                     ------------    ------------

 Income from Operations                 2,224,597         685,717

 Interest income                          430,593         347,837
 Interest expense                          (1,883)            (15)
 Other income (expense), net                 (116)        (59,360)
                                     ------------    ------------

 Income (loss) before income taxes      2,653,191         974,179
 Provision (credit) for income
  taxes                                 1,135,610         477,062
                                     ------------    ------------

 Net Income (loss)                   $  1,517,581    $    497,117
                                     ============    ============


 Income per common and common
  equivalent shares
 Basic                               $       0.02    $       0.01
 Diluted                             $       0.02    $       0.01

 Weighted average number of common
  and common equivalent shares
  outstanding
 Basic                                 62,035,485      61,319,959
 Diluted                               64,137,109      63,951,739


                       TASER International, Inc.
                         Statements of Income
                              (Unaudited)

                                       For the Six Months Ended
                                       ------------------------
                                    June 30, 2006   June 30, 2005
                                    -------------   -------------

 Net Sales                           $ 30,118,760    $ 23,410,820
                                     ------------    ------------

 Cost of Products Sold:
 Direct manufacturing expense           7,758,785       6,635,876
 Indirect manufacturing expense
  (including stock-based
  compensation expense of $62,545
  and $0, respectively)                 3,014,658       3,018,281
                                     ------------    ------------

 Total Cost of Products Sold           10,773,443       9,654,157
                                     ------------    ------------

 Gross Margin                          19,345,317      13,756,663

 Sales, general and administrative
  expenses (including stock-based
  compensation expense of $500,380
  and $0, respectively)                14,857,347      12,517,642
 Research and development expenses
  (including stock-based
  compensation expense of $110,723
  and $0, respectively)                 1,226,801         742,904
                                     ------------    ------------

 Income from Operations                 3,261,169         496,117

 Interest income                          798,028         546,712
 Interest expense                          (3,890)           (103)
 Other income (expense), net                 (228)        (59,735)
                                     ------------    ------------

 Income (loss) before income taxes      4,055,079         982,991
 Provision (credit) for income taxes    1,731,519         480,481
                                     ------------    ------------

 Net Income (loss)                   $  2,323,560    $    502,510
                                     ============    ============


 Income per common and common
  equivalent shares
 Basic                               $       0.04    $       0.01
 Diluted                             $       0.04    $       0.01

 Weighted average number of common
  and common equivalent shares
  outstanding
 Basic                                 61,990,714      61,209,420
 Diluted                               64,089,746      64,152,543


                       TASER International, Inc.
                            Balance Sheets
                              (Unaudited)

                                      June 30, 2006   December 31, 2005
                                      -------------   -----------------

                                ASSETS

 Current Assets
 Cash and cash equivalents             $ 15,419,832     $ 16,351,909
 Short-term investments                   5,110,858               --
 Accounts receivable, net                 7,807,840        5,422,027
 Inventory                                9,605,618       10,105,336
 Prepaids and other assets                1,271,303        2,795,576
 Insurance settlement proceeds receivable        --          575,000
 Income tax receivable                        1,754           44,454
 Current deferred income tax asset        7,125,482        6,955,500
                                       ------------     ------------

 Total Current Assets                    46,342,687       42,249,802
 Long-term investments                   28,612,203       27,548,120
 Property and equipment, net             21,034,034       21,061,754
 Deferred income tax asset               18,284,488       20,040,788
 Intangible assets, net                   1,421,697        1,340,783
                                       ------------     ------------

 Total Assets                          $115,695,109     $112,241,247
                                       ============     ============

                 LIABILITIES AND STOCKHOLDERS' EQUITY

 Current Liabilities
 Current portion of capital lease 
  obligations                          $     44,137     $     43,111
 Accounts payable and accrued 
  liabilities                             6,064,541        6,315,654
 Current deferred revenue                   722,590          561,165
 Deferred insurance settlement proceeds     439,226          476,515
 Customer deposits                          203,233          190,256
                                       ------------     ------------

 Total Current Liabilities                7,473,727        7,586,701
 Capital lease obligations, net of 
  current portion                            53,856           76,188
 Deferred revenue, net of current 
  portion                                 1,164,777          839,983
                                       ------------     ------------

 Total Liabilities                        8,692,360        8,502,872
                                       ------------     ------------

 Commitments and Contingencies                   --               --

 Stockholders' Equity
 Common stock                                   620              619
 Additional paid-in capital              79,683,675       78,742,862
 Retained earnings                       27,318,454       24,994,894
                                       ------------     ------------

 Total Stockholders' Equity             107,002,749      103,738,375
                                       ------------     ------------

 Total Liabilities and Stockholders' 
  Equity                               $115,695,109     $112,241,247
                                       ============     ============


                       TASER International, Inc.
             Selected Statement of Cash Flows Information
                              (Unaudited)
 
                                            For the Six Months Ended
                                         June 30, 2006   June 30, 2005
                                         -------------   -------------

 Net income                              $  2,323,560    $    502,510
 Depreciation and amortization              1,043,069         706,055
 Stock-based compensation expense             673,648              --
 Net cash provided (used) by operating 
  activities                                6,093,267        (714,791)
 Net cash provided (used) by investing 
  activities                               (7,271,204)      1,980,294
 Net cash provided by financing 
  activities                                  245,860         438,961
 Cash and Cash Equivalents, end of period  15,419,832      16,461,623


            

Contact Data